0. Scope and important disclaimers

1. Where the rules apply: Nasdaq Capital Market vs Global Market

Nasdaq has several tiers; for most small biotech and growth names, the relevant tier is the Nasdaq Capital Market. This is where:

• many micro/small caps trade, especially life sciences and tech;
• the$1.00 minimum bid price rule (Rule 5550(a)(2))applies as a condition for continued listing;
• other conditions include minimum market value of publicly held shares, number of shareholders, and equity tests.

The same $1.00 requirement also appears in the rule set for Nasdaq Global and Global Select, but the financial thresholds are higher. For most biotech traders, the “$1 rule” on the Capital Market is the one that matters day to day.

2. The Nasdaq $1.00 minimum bid price rule – step by step

2.1 When does a violation occur?

2.2 The initial 180-day compliance period

2.3 The second 180-day period

3. Other common Nasdaq listing deficiencies (short overview)

The $1.00 bid price is not the only way a stock can fall out of compliance. Other frequent triggers include:

• Market value of listed securities / publicly held shares– if the market value of publicly held shares stays below certain thresholds for 30 days, Nasdaq can issue a deficiency notice.
• Shareholders’ equity– if the company’s equity falls below required levels, especially after cumulative losses.
• Late SEC filings– failure to timely file Forms 10-K or 10-Q can trigger its own deficiency notice and a separate delisting track.
• Corporate governance criteria– e.g. insufficient independent directors, lack of audit committee, etc.

In practice, many microcaps get flagged both for price and for other criteria simultaneously; this can accelerate delisting or limit the ability to obtain extensions.

4. What companies can do: tools and limitations

4.1 Organic recovery (best but hardest)

In theory, the “cleanest” way to fix a bid price deficiency is simply:

• execute on the business, deliver positive news (data, deals, profitability),
• and let the market push the price back above $1.00 on its own for the required 10+ days.

This is what Nasdaq prefers, but in practice many distressed small caps cannot reliably count on it in a limited window.

4.2 Reverse stock split

4.3 Improving fundamentals and capital structure

Beyond splits, more fundamental levers include:

• raising capital on better terms (hard in distressed situations);
• reducing debt, renegotiating covenants;
• strategic transactions (M&A, asset sales, licensing) that change the risk profile.

In practice, many microcaps end up mixing business actions with structural ones (reverse split + financing + cost cuts).

5. From deficiency to delisting: notices, hearings, OTC

5.1 Deficiency notice vs delisting determination

It is crucial to distinguish between:

• adeficiency notice(for example “we received a notice from Nasdaq that we are out of compliance with the $1 minimum bid requirement”), and
• adelisting determination, where Nasdaq informs the company that its securities are subject to delisting.

The first doesnotimmediately remove the listing; it starts the 180-day (and possibly additional) compliance periods. The second is much closer to the actual removal from the exchange.

5.2 Hearings and the automatic stay

6. Market reaction to deficiency, delisting and regaining compliance

6.1 When the deficiency / delisting notice is announced

Several studies have looked at how the market reacts when companies file an 8-K disclosing a quantitative listing deficiency, such as falling below the minimum bid price:

• One 2022 study onForm 8-K deficiency noticesfinds that investors, on average, react with negative abnormal returnsaround the announcement date, especially when institutional ownership is low.
• The magnitude is usually in the single-digit percentage range over the event window, but there is huge variation between individual stocks (some barely move, others drop sharply).

In plain language: when the market officially learns that the exchange has flagged a listing problem, this is usually treated asbad newsand the price often moves lower on average – but not always, and not by a fixed amount.

6.2 On the actual delisting day

Older work on Nasdaq delistings (e.g., studies covering 1990s–2000s samples) shows that:

• a portfolio of Nasdaq stocks that are actually delisted and move to OTC can lose on the order of ~18–20% of value on the delisting dayon average (equal-weighted vs value-weighted portfolios), even though the market has advance warning.
• After delisting, liquidity often deteriorates and bid/ask spreads widen on OTC venues, although the long-term impact on fundamentals is more nuanced and depends on the company.

Again: these are sample averages from historical data, not a forecast. Some stocks had much bigger drops; others were already so depressed that the incremental move was smaller.

6.3 Reverse split announcements

Empirically, reverse split announcements often trigger:

• short-term speculative moves(sometimes a pop, sometimes a selloff) as traders reposition around the split date,
• and in many cases,weak medium-term performancefor distressed issuers that used the split simply as a compliance tool without resolving deeper problems.

However, there are also cases where a reverse split is part of a broader turnaround (cleaning up the cap table, uplisting, new business plan). In those situations, performance depends much more on the fundamentals than on the split itself.

6.4 Announcements of regaining compliance

7. Practical checklist for small traders

8. Official sources and further reading

A non-exhaustive list of useful primary and secondary sources on Nasdaq listing rules, minimum bid price compliance and reverse split changes:

• Nasdaq Listing Rules – 5800 Series (including Rule 5550 and 5810):
  https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series
• SEC order approving amendments to Nasdaq minimum bid price compliance periods (Rule 5810(c)(3)(A)):
  https://www.sec.gov/files/rules/sro/nasdaq/2025/34-102245.pdf
• Dentons – “U.S. exchanges overhaul bid price compliance rules” (Oct 25, 2024):
  https://www.dentons.com/…/us-exchanges-overhaul-bid-price-compliance-rules
• Morgan Lewis – “Nasdaq proposes stricter delisting rules for noncompliance with minimum bid price requirement” (Sep 6, 2024):
  https://www.morganlewis.com/…/nasdaq-proposes-stricter-delisting-rules
• Norton Rose Fulbright – “New Nasdaq and NYSE rules on use of reverse stock splits”:
  https://www.nortonrosefulbright.com/…/new-nasdaq-and-nyse-rules-on-use-of-reverse-stock-splits
• Academic work on deficiency notices and delisting:
  – Guragai (2022), “Market response to stock exchange listing deficiency notices”.
  – Harris et al. (2008), “Off but not gone: A study of Nasdaq delistings”.
  – Rhee & Wu (2012), Li et al. (2024) and others, on long-term effects of delisting on liquidity and capital access.